ERY-TAB is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals, Inc.. The primary component is Erythromycin.
Product ID | 24338-126_f7f33758-f601-4397-baa4-30286a9a3a39 |
NDC | 24338-126 |
Product Type | Human Prescription Drug |
Proprietary Name | ERY-TAB |
Generic Name | Erythromycin |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2011-04-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA062298 |
Labeler Name | Arbor Pharmaceuticals, Inc. |
Substance Name | ERYTHROMYCIN |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-11-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA062298 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-11-17 |
Marketing Category | ANDA |
Application Number | ANDA062298 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-18 |
Ingredient | Strength |
---|---|
ERYTHROMYCIN | 500 mg/1 |
SPL SET ID: | fda44eb6-7901-4b80-ba0b-216f6cacf3fd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
21695-457 | ERY-TAB | erythromycin |
24338-122 | ERY-TAB | Erythromycin |
24338-124 | ERY-TAB | Erythromycin |
68151-1170 | ERY-TAB | ERY-TAB |
68151-1174 | ERY-TAB | ERY-TAB |
24338-126 | ERY-TAB | ERY-TAB |
43063-569 | ERY-TAB | ERY-TAB |
50090-0339 | ERY-TAB | ERY-TAB |
55289-217 | ERY-TAB | ERY-TAB |
55289-525 | ERY-TAB | ERY-TAB |
0378-8075 | ERYGEL | erythromycin |
0093-5571 | Erythromycin | Erythromycin |
0093-5572 | Erythromycin | Erythromycin |
0168-0215 | Erythromycin | erythromycin |
0168-0216 | Erythromycin | erythromycin |
0378-8212 | Erythromycin | erythromycin |
0404-7191 | Erythromycin | Erythromycin |
0574-4024 | erythromycin | erythromycin |
13668-586 | ERYTHROMYCIN | ERYTHROMYCIN |
13668-588 | ERYTHROMYCIN | ERYTHROMYCIN |
13668-606 | Erythromycin | Erythromycin |
13668-607 | Erythromycin | Erythromycin |
13985-605 | Erythromycin | Erythromycin |
17478-070 | Erythromycin | Erythromycin |
17478-824 | Erythromycin | Erythromycin |
21695-173 | Erythromycin | Erythromycin |
24208-910 | Erythromycin | Erythromycin |
24338-102 | Erythromycin | Erythromycin |
24338-104 | Erythromycin | Erythromycin |
24338-120 | ERYTHROMYCIN | Erythromycin |
21695-387 | ERYTHROMYCIN Base Filmtab | ERYTHROMYCIN |
21695-389 | ERYTHROMYCIN Base Filmtab | ERYTHROMYCIN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ERY-TAB 73286993 1211217 Live/Registered |
Abbott Laboratories 1980-11-21 |